首页 > 市场调查报告书 > 製药

非专利药

市场调查报告书

商品编码

1935245

特种注射用学名药市场按产品类型、应用、通路和地区划分

Specialty Injectable Generics Market, By Product Type, By Application, By Distribution Channel, By Geography

出版日期: 2026年01月22日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2026 年，特种注射剂学名药市场规模将达到 217.8 亿美元，到 2033 年将达到 366.2 亿美元，2026 年至 2033 年的复合年增长率为 7.8%。

报告内容		报告详情
基准年：	2025	2026年市场规模：	217.8亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	7.80%	预计2033年价值：	366.2亿美元

特殊注射药物是高成本的药物，必须透过注射、吸入或静脉输注来治疗慢性或危及生命的疾病，例如 HIV、类风湿性关节炎、血友病、癌症、心血管疾病、感染疾病、自体免疫疾病和其他疾病。

市场动态

癌症和心血管疾病等慢性病的日益普及是推动特种注射剂非专利市场成长的主要因素。据美国国家癌症研究所（2013）称，癌症根据其起源细胞类型可分为100多种类型。美国癌症协会（2017）的报告显示，癌症是美国第二大死因，约占所有死亡人数的四分之一。

此外，预计在不久的将来，大量医药和生物技术产品的专利将到期，尤其是在高价值的美国和欧洲市场，这将进一步推动市场成长。

然而，严格的监管准则、较低的利润率以及药品短缺预计将阻碍全球仿製特种注射学名药市场的成长。该行业面临的短缺主要源于生产问题日益增多、供应延迟以及原料药（API）短缺。

本次调查的主要特点

本报告对特种注射学名药市场进行了详细分析，以 2017 年为基准年，给出了预测期（2018-2026 年）内的市场规模和复合年增长率。
它还重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
该报告根据以下参数对全球特种注射学名药市场的主要企业进行了分析：公司概况、财务业绩、产品系列、市场地位、分销策略、主要发展、战略和未来计划。
本报告的研究结果将使负责人和经营团队能够就即将推出的产品、技术升级、市场扩张和行销策略做出明智的决策。
这份全球特种注射学名药市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过各种策略矩阵轻鬆做出决策，这些矩阵用于分析特种注射用学名药市场。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第八章竞争情势

热图分析
市占率分析（3x3矩阵）
公司简介
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Baxter International Inc.
- Mylan NV
- Fresenius SE &Co. KGaA
- Endo International Plc.
- Hikma Pharmaceuticals PLC
- Lupin Ltd.
- Sagent Pharmaceuticals, Inc.
- Cipla Limited
- Sun Pharmaceutical Industries Limited,
- Dr. Reddy's Laboratories

第九章分析师建议

机会
分析师观点
Coherent Opportunity Map

第十章各节

参考
调查方法

简介目录

Product Code: CMI1877

Specialty Injectable Generics Market is estimated to be valued at USD 21.78 Bn in 2026 and is expected to reach USD 36.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 21.78 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.80%	2033 Value Projection:	USD 36.62 Bn

Specialty injectable is a high cost drug therapy that requires administration by injection, inhalation or infusion. This medication is indicated in treatment of chronic or life threatening diseases such as HIV, rheumatoid arthritis, hemophilia, cancer, cardiovascular diseases, infectious diseases, auto immune disorders, and other diseases.

Market Dynamics

Increasing prevalence of chronic diseases such as cancer and cardiovascular diseases is a major factor driving the specialty injectable generics market growth. According to The National Cancer Institute, 2013, there are over 100 different types of cancers that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

Moreover, expiration of the patents of majority of pharmaceutical and biotech products in the near future, especially in high value U.S. and Europe market is boosting the market growth.

However, stringent regulatory guidelines and low profit margins and drug shortage is expected to hamper growth of the global specialty injectable generics market. The shortages faced in the industry are primarily due to increased manufacturing issues, delay in supply, and shortage of Active Pharmaceutical Ingredients (API).

Key features of the study

This report provides in-depth analysis of the specialty injectable generics market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global specialty injectable generics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Baxter International Inc., Mylan N.V., Fresenius SE & Co. KGaA, Endo International Plc., Hikma Pharmaceuticals PLC, Lupin Ltd., Sagent Pharmaceuticals, Inc., Cipla Limited , Sun Pharmaceutical Industries Limited, and Dr. Reddy's Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global specialty injectable generics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the specialty injectable generics market

Market Segmentation

By Product Type
- Drugs
- Biologics
By Application
- Oncology
- Cardiovascular Diseases
- Central Nervous System Diseases
- Infectious Diseases
- Auto-immune Disorders
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Baxter International Inc.
- Mylan N.V.
- Fresenius SE & Co. KGaA
- Endo International Plc.
- Hikma Pharmaceuticals PLC
- Lupin Ltd.
- Sagent Pharmaceuticals, Inc.
- Cipla Limited
- Sun Pharmaceutical Industries Limited
- Reddy's Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Specialty Injectable Generics Market, By Product Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Drugs
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Biologics
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Specialty Injectable Generics Market, By Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cardiovascular Disease
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Central Nervous System Disease
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Infectious Disease
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Auto-immune Disorders
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Specialty Injectable Generics Market, By Distribution Channel, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Specialty Injectable Generics Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Pfizer, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Novartis AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Baxter International Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Mylan N.V.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Fresenius SE & Co. KGaA
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Endo International Plc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Hikma Pharmaceuticals PLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Lupin Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sagent Pharmaceuticals, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cipla Limited
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sun Pharmaceutical Industries Limited,
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Dr. Reddy's Laboratories
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates

9. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

特种注射用学名药市场按产品类型、应用、通路和地区划分

Specialty Injectable Generics Market, By Product Type, By Application, By Distribution Channel, By Geography

市场动态